Mimvey recalls
Mimvey products have been recalled 2 times, most recently on 9 Feb 2022. The recalling company is usually Teva Pharmaceuticals USA. The most common reason is labeling errors.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 9 Feb 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why mimvey is recalled
Companies
Product types
By year
All mimvey recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Mimvey (estradiol and norethindrone acetate tablets USP) recalledMimvey | Teva Pharmaceuticals USA | Labeling Errors | Nationwide |
| Drug | CLASS III | Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg recalledMimvey | Teva Pharmaceuticals USA | Labeling Errors | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.